Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data

Early detection of dementia in Parkinson disease is a prerequisite for preventive therapeutic approaches. Modified serpinA1 in cerebrospinal fluid (CSF) was suggested as an early biomarker for differentiation between Parkinson patients with (PDD) or without dementia (PD). Within this study we aimed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Halbgebauer, Steffen, Nagl, Magdalena, Klafki, Hans, Haußmann, Ute, Steinacker, Petra, Oeckl, Patrick, Kassubek, Jan, Pinkhardt, Elmar, Ludolph, Albert C., Soininen, Hilkka, Herukka, Sanna-Kaisa, Wiltfang, Jens, Otto, Markus
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868992/
https://ncbi.nlm.nih.gov/pubmed/27184740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep26145
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak